The US Supreme Court will hear generic drug maker Hikma Pharmaceuticals USA Inc.'s challenge of an appeals court holding that ...
The Supreme Court agreed to review a controversy over so-called skinny labels for medicines, a decision that will be closely ...
In taking the unusual step of approving an old generic drug as a treatment for autism, the Food and Drug Administration stunned some experts by departing sharply from the agency’s typical standard for ...
Forbes contributors publish independent expert analyses and insights. The U.S. spent $722.5 billion on pharmaceuticals in 2023. Although brand-name drugs consume four out of every 5 dollars America ...
The amount of generic rivals available in relation to a brand name treatment can affect drug costs, according to a report in the Journal of the American Medical Association. Researchers identified all ...
The U.S. Food and Drug Administration has delayed reviews of several drugs selected for the Trump administrations new ...
Connecticut data from 2022 to 2023 show medications from retail pharmacies accounted for the state's highest health care ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback